For more than 15 years, Michelle Morand has worked alongside people navigating cancer, helping them answer a deceptively difficult question: How do I know whether I have the information I need to make a good decision?
As co-founder of Cancer Treatment Options and Management (CTOAM) and Liquid Biopsy Labs, Michelle has helped build an international network of physicians, scientists, pathologists, researchers, laboratories and patient advocates across North America, South America, Europe and China — connected by a shared goal of helping people access the most useful information possible, as early as possible, to support more informed and individualized cancer care.
Her particular expertise is problem-solving.
What do we already know? What might we be missing? What does the evidence actually say? Is something truly not possible, or have we encountered a roadblock that deserves another question? Who else should we ask? And if we learn something new, what reasonable difference could it make?
Michelle combines this experience with more than 35 years in counselling, education and program development. Her background in human behaviour and critical thinking brings another important dimension to cancer advocacy: Helping people recognize when fear, hope, authority, assumptions or bias may be influencing how they interpret information and make decisions.
She doesn't believe patients should automatically distrust their doctors — or automatically defer to them.
Nor should they automatically trust something simply because it sounds promising or challenges conventional medicine.
The question is: How do we know?
Through Cancer Just the Facts and Questions Worth Asking, Michelle helps people become better-informed, better-prepared participants in their care — able to ask better questions, evaluate the answers they receive, prepare for important healthcare conversations, and know where to look when more information is needed.
Because sometimes the most important question is the one nobody thought to ask. |
